UnitedHealthcare posted its June 2026 Reimbursement Policy Update Bulletins on June 1, 2026, and the commercial bulletin is unusual. It contains no changes to E/M, modifiers or surgical payment. Instead, all five new policies are about laboratory testing, and all five take effect for dates of service on or after September 1, 2026. If your practice draws blood in the office, orders labs that bill under your tax ID, or runs an allergy, endocrinology, hepatology or oncology service line, this bulletin is going to change what gets paid in the fall.
The pattern is familiar to anyone who has watched payer bulletins for a few years. A payer groups a set of tests under a "Routine Test Management" heading, writes a frequency limit or a covered-indication list for each, and gives ninety days' notice. The tests keep getting ordered at the same rate, the claims start denying in September, and the practice discovers the policy in October. We would rather you discover it in June.
A glossary line first: a reimbursement policy is a payer's statement of how it will pay a claim that is otherwise covered, as opposed to a medical policy, which decides whether a service is covered at all. Frequency limits and "not considered for reimbursement" lists live in reimbursement policies, and they are applied by the claim system automatically, usually without a records request.
Key takeaways
- The UnitedHealthcare June 2026 bulletin introduces five new commercial policies, all under Routine Test Management, effective September 1, 2026, in every state except Arkansas, Colorado, Kentucky, North Carolina, Nebraska, Ohio and Rhode Island, where a later notice will follow.
- Vitamin B12 testing will be reimbursed up to once every three months; hepatic fibrosis multianalyte assays up to once every six months; specific IgE allergy testing up to twenty allergen-specific antibodies per year for patients aged 20 and over.
- In vitro chemotherapy sensitivity and resistance assays will not be reimbursed at all.
- Testosterone testing gets a covered-indication list and frequency limits, including SHBG once annually for hypogonadism and estradiol once per lifetime before testosterone therapy in males with gynecomastia.
- Separately, HCPCS S9443 (lactation classes) joins the Preventive Medicine and Screening policy on September 1 and is payable only with the mother as the patient, one session per date of service.
The five new policies, one by one
The full policy documents were scheduled to be posted on uhcprovider.com on June 8, 2026. The bulletin summaries are enough to plan from, and here is what each says.
| Policy (Professional and Facility) | What will be reimbursed | What will not |
|---|---|---|
| Allergen Testing | In vitro serum IgE testing for patients 20 and older with moderate to severe asthma or signs of allergic bronchopulmonary aspergillosis; specific IgE testing up to 20 allergen-specific antibodies per year for patients 20 and older | ALCAT testing; basophil activation flow cytometry; IgG, IgA, IgM or IgD testing for allergy symptoms; bead-based epitope assays; qualitative multi-allergen screens that do not identify a specific allergen |
| Hepatic Fibrosis Testing for Chronic Liver Disease | Multianalyte assay testing up to once every six months to distinguish cirrhosis from non-cirrhosis in hepatitis B, hepatitis C, MASLD (including MASH) or alcoholic hepatitis | Certain other multianalyte assays |
| In Vitro Chemotherapy Assays | Nothing | In vitro chemotherapy sensitivity and resistance assays |
| Testosterone | Total testosterone for treatment monitoring in listed populations; free testosterone, SHBG and/or albumin up to once annually for males with hypogonadism, gynecomastia or other testicular hypofunction; bioavailable testosterone calculations for suspected SHBG disorders; estradiol once per lifetime before testosterone therapy in males with gynecomastia; DHT for 5-alpha reductase deficiency in listed conditions | Total, free or bioavailable testosterone for asymptomatic individuals or non-specific symptoms |
| Vitamin B12 Testing | Total vitamin B12 up to once every three months; homocysteine testing for B12 deficiency | Anything beyond the frequency limit |
The codes these policies will touch are the ones your lab interface already knows: 86003 (allergen-specific IgE, each allergen) and 86005 (multi-allergen screen) for the allergy policy; 82607 (B12) and 83090 (homocysteine) for the B12 policy; 84403 (total testosterone), 84402 (free testosterone), 84270 (SHBG), 82670 (estradiol) and 82651 (dihydrotestosterone) for the testosterone policy; and multianalyte assay codes such as 81596 and the 0000U-series PLA codes for hepatic fibrosis. We have not seen the code tables inside the posted policies yet, so treat this list as where to look, not as the payer's list.
Where the money is
Individually these are small-dollar tests. The B12 policy is the one that will produce the most denials by count, because B12 is ordered reflexively in primary care, often on every metabolic panel for older patients on metformin, and "every three months" will collide with patients seen monthly. The allergen policy will produce the most denials by dollar in allergy and ENT practices, because a panel of 40 specific IgE antigens billed as 40 units of 86003 becomes 20 paid units and 20 denied.
A worked example. An allergy practice bills 86003 at 30 units per new patient panel and sees 25 new patients a month under UnitedHealthcare commercial plans. At a contracted rate we will call $7 per unit, the panel is $210. From September 1, units above 20 in the year are not reimbursed, so each panel loses $70, or $1,750 a month, and every repeat panel in the same year loses everything above the cap. The practice has three choices: change the panel, bill the patient with an advance notice where the plan allows, or absorb it. What it cannot do is nothing.
The oncology assay policy is a hard stop, not a limit, and practices that order those tests should confirm whether the reference lab will bill the patient or the practice for denied claims.
The S9443 change and the code update list
Two other items in the commercial bulletin are easy to overlook. First, effective September 1, 2026, HCPCS S9443 (lactation classes, non-physician provider, per session) is added to the Preventive Medicine and Screening Policy, Professional. UnitedHealthcare says it will reimburse the code only when the claim lists the mother as the patient, one session per date of service, and will not reimburse claims submitted for the infant. Pediatric and OB practices that have been billing lactation support under the baby's coverage should change the workflow now, not in September.
Second, the bulletin lists seven policies that received code updates with no change in intent: Contrast and Radiopharmaceutical Materials (Professional), Device and Skin Substitute (Facility), Maximum Frequency per Day (Professional), Outpatient Hospital Add-On Codes (Facility), Outpatient Hospital Observation (Facility), Professional/Technical Component (Professional) and Supply (Professional). "No change in intent" does not mean no change in payment. The Maximum Frequency per Day policy in particular picks up unit limits when code sets change, and the details are in the history section at the end of each posted policy. Open the two on that list that match your specialty.
What else was in the June overview
UnitedHealthcare's June 2026 policy and protocol overview, published alongside the bulletins, flags several prior authorization changes that share the September 1, 2026 effective date: exclusion of certain injectable oncology drugs where equivalent alternatives exist, new prior authorization codes for vertebral body tethering and extremity prosthetics in select Medicaid states, and additional advanced imaging codes joining the outpatient radiology prior authorization program. New Mexico Medicaid providers also face a state enrollment requirement effective July 1, 2026. None of these are reimbursement policy changes, but they land on the same day, and a practice that schedules imaging or infusions should read the full overview.
If tracking monthly bulletins across UnitedHealthcare, Aetna, Cigna, Humana and your regional Blue plan is not something anyone in the office has time for, our medical billing team does it as part of monthly reporting, and the denial management service includes a payer policy exposure review.
Questions we hear
Does this apply to UnitedHealthcare Medicare Advantage or Medicaid plans?
The five new policies are in the commercial bulletin. UnitedHealthcare posts separate June 2026 bulletins for Medicare Advantage, Community Plan (Medicaid) and Individual Exchange plans, and the Medicare Advantage products generally follow CMS coverage rules for lab frequency. Check each bulletin for your plan mix rather than assuming.
Can we bill the patient for a B12 test above the frequency limit?
That depends on your contract and on whether the plan treats the excess as non-covered (patient may be billed with proper notice) or as a provider write-off. Read the participation agreement's hold-harmless clause, and where patient billing is allowed, have the notice signed before the draw, not after the denial.
Why are seven states excluded?
The bulletin says only that UnitedHealthcare will issue a later notification for Arkansas, Colorado, Kentucky, North Carolina, Nebraska, Ohio and Rhode Island. In our experience this usually reflects state regulatory filing requirements rather than an intention to exempt those states. If you practice in one of them, expect a later effective date, not an exemption.
What to do this week
- Pull twelve months of UnitedHealthcare commercial claims for 82607, 83090, 86003, 86005, 84403, 84402, 84270 and 82670 and count how many would exceed the new limits.
- Open the posted policies on uhcprovider.com after June 8 and copy the code tables into your payer policy file.
- Share the B12 and testosterone frequency limits with ordering providers and update standing order sets.
- If you bill S9443, change registration so the mother is the patient on the claim before September 1.
- Read the history section of the Maximum Frequency per Day and Supply policies for unit-limit changes on codes you bill.
- Put September 1, 2026 on the billing calendar with a reminder to run a denial report on these codes in the first week of October.
